Miller, David
Vaidya, Soniya
Jauernig, Juergen
Ethell, Brian
Wagner, Kristina
Radhakrishnan, Rajkumar
Tillmann, Hanns-Christian
Funding for this research was provided by:
Novartis Pharma AG
Article History
Received: 16 April 2020
Accepted: 6 September 2020
First Online: 23 September 2020
Ethics approval and consent to participate
: The study was conducted according to the ethical principles of the Declaration of Helsinki. Informed consent was obtained from all the study participants prior to initiation.
: Not applicable.
: *Soniya Vaidya was an employee of Novartis Institutes for BioMedical Research, Inc., Cambridge, MA during the conduct of the study.The authors received no compensation related to the development of the manuscript. Hanns-Christian (HCT) is an employee of and holds shares of Novartis Pharma AG. Brian Ethell (BE) is an employee of and holds shares of Novartis Pharma AG. Juergen Jauernig (JJ) is an employee and shareholder of Novartis Pharma AG. Dr. Soniya Vaidya (SV) is an employee of Axcella Health, Inc. and shareholder of Novartis Pharma AG.Dr. S. David Miller does not report any conflict of interest (DV). The authors reported no conflict of interest relevant to the work presented here.